Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny L Moore

Showing results (31-40 of 214) with videos related to

Pageof 22
Sort By:
Mbio|September 20, 2022
Building a Resilient Scientific Network for COVID-19 and BeyondN Esther Babady, Rachel M Burckhardt, Florian Krammer, et al.
AIDS (London, England)|May 8, 2025
Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?Philippe Van de Perre, Penny L Moore, Nicolas Nagot, et al.
Vaccines|February 28, 2023
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate VaccinesRosamund Chapman, Michiel van Diepen, Nicola Douglass, et al.
Journal of Virology|June 29, 2018
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known EpitopesZanele Ditse, Maximilian Muenchhoff, Emily Adland, et al.
Journal of Virology|December 21, 2018
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing AntibodiesBatsirai M Mabvakure, Cathrine Scheepers, Nigel Garrett, et al.
Plos Pathogens|September 4, 2019
Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineageDavid Sacks, Jinal N Bhiman, Kevin Wiehe, et al.
Nature Communications|October 28, 2018
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virionsConstantinos Kurt Wibmer, Simone I Richardson, Jason Yolitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not ProtectionJeffrey R Dorfman, Sashkia R Balla, Jayani Pathirana, et al.
Antiviral Therapy|June 25, 2008
Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinantRichard D Sloan, Samreen Ijaz, Penny L Moore, et al.
Bioinformatics and Biology Insights|February 17, 2022
Advancing HIV Vaccine Research With Low-Cost High-Performance Computing Infrastructure: An Alternative Approach for Resource-Limited SettingsBatsirai M Mabvakure, Raymond Rott, Leslie Dobrowsky, et al.
Pageof 22

Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
Mbio|September 20, 2022
Building a Resilient Scientific Network for COVID-19 and BeyondN Esther Babady, Rachel M Burckhardt, Florian Krammer, et al.
AIDS (London, England)|May 8, 2025
Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?Philippe Van de Perre, Penny L Moore, Nicolas Nagot, et al.
Vaccines|February 28, 2023
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate VaccinesRosamund Chapman, Michiel van Diepen, Nicola Douglass, et al.
Journal of Virology|June 29, 2018
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known EpitopesZanele Ditse, Maximilian Muenchhoff, Emily Adland, et al.
Journal of Virology|December 21, 2018
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing AntibodiesBatsirai M Mabvakure, Cathrine Scheepers, Nigel Garrett, et al.
Plos Pathogens|September 4, 2019
Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineageDavid Sacks, Jinal N Bhiman, Kevin Wiehe, et al.
Nature Communications|October 28, 2018
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virionsConstantinos Kurt Wibmer, Simone I Richardson, Jason Yolitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not ProtectionJeffrey R Dorfman, Sashkia R Balla, Jayani Pathirana, et al.
Antiviral Therapy|June 25, 2008
Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinantRichard D Sloan, Samreen Ijaz, Penny L Moore, et al.
Bioinformatics and Biology Insights|February 17, 2022
Advancing HIV Vaccine Research With Low-Cost High-Performance Computing Infrastructure: An Alternative Approach for Resource-Limited SettingsBatsirai M Mabvakure, Raymond Rott, Leslie Dobrowsky, et al.
Pageof 22